Schedule of Quarterly Financial Information [Table Text Block] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year 2014 Quarter Ended |
|
June 30, 2013 |
|
Sept. 30, 2013 |
|
Dec. 31, 2013 |
|
Mar. 31, 2014 |
(in thousands, except per share amounts) |
|
|
|
|
|
|
|
Revenue |
$ |
22,456 |
|
|
$ |
29,960 |
|
|
$ |
25,236 |
|
|
$ |
24,421 |
|
Gross profit |
8,776 |
|
|
12,423 |
|
|
12,235 |
|
|
8,524 |
|
Total operating expenses |
11,377 |
|
|
11,129 |
|
|
10,212 |
|
|
12,554 |
|
Income (loss) before income taxes and discontinued operations |
(2,731 |
) |
|
1,392 |
|
|
1,992 |
|
|
(4,023 |
) |
Income tax (expense) benefit |
(19 |
) |
|
(68 |
) |
|
(38 |
) |
|
8,907 |
|
Net income (loss) from continuing operations |
(2,750 |
) |
|
1,324 |
|
|
1,954 |
|
|
4,884 |
|
Income (loss) from discontinued operations, net of tax |
(14 |
) |
|
4 |
|
|
(29 |
) |
|
(6 |
) |
Net income (loss) |
(2,764 |
) |
|
1,328 |
|
|
1,925 |
|
|
4,878 |
|
Net income (loss) per common share: |
|
|
|
|
|
|
|
Basic |
$ |
(0.05 |
) |
|
$ |
0.02 |
|
|
$ |
0.03 |
|
|
$ |
0.08 |
|
Diluted |
$ |
(0.05 |
) |
|
$ |
0.02 |
|
|
$ |
0.03 |
|
|
$ |
0.08 |
|
The Company acquired Kentrox on April 1, 2013 and CSI on March 1, 2014. In the fourth quarter of fiscal 2014, deferred tax liabilities of $9.1 million resulted from the acquisitions relating primarily to acquired intangible assets. The Company's anticipated ability to realize deferred tax assets from the reversal of these deferred tax liabilities resulted in a reversal of valuation allowance which was recorded in the fourth quarter of fiscal year 2014.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year 2013 Quarter Ended |
|
June 30, 2012 |
|
Sept. 30, 2012 |
|
Dec. 31, 2012 |
|
Mar. 31, 2013 |
(in thousands, except per share amounts) |
|
|
|
|
|
|
|
Revenue |
$ |
9,418 |
|
|
$ |
9,854 |
|
|
$ |
8,873 |
|
|
$ |
10,663 |
|
Gross profit |
2,773 |
|
|
3,449 |
|
|
3,090 |
|
|
4,013 |
|
Total operating expenses |
6,271 |
|
|
5,701 |
|
|
5,606 |
|
|
9,072 |
|
Income (loss) before income taxes and discontinued operations |
(3,414 |
) |
|
(2,245 |
) |
|
(2,473 |
) |
|
(5,018 |
) |
Income tax (expense) benefit |
1,247 |
|
|
677 |
|
|
1,295 |
|
|
(32,611 |
) |
Net income (loss) from continuing operations |
(2,167 |
) |
|
(1,568 |
) |
|
(1,178 |
) |
|
(37,629 |
) |
Income (loss) from discontinued operations, net of tax |
427 |
|
|
(607 |
) |
|
(787 |
) |
|
(529 |
) |
Net income (loss) |
(1,740 |
) |
|
(2,175 |
) |
|
(1,965 |
) |
|
(38,158 |
) |
Net income (loss) per common share: |
|
|
|
|
|
|
|
Basic |
$ |
(0.03 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.66 |
) |
Diluted |
$ |
(0.03 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.66 |
) |
|